ÒøºÓ¼¯ÍŹÙÍø

²úÆ·¿ÆÆÕ | ÄÔ´úл¸ÄÉÆÒ©¡ª¡ªßÁÀ­Î÷̹Ƭ

ʱ¼ä£º

2024-10-11

²úÆ·¿ÆÆÕ | ÄÔ´úл¸ÄÉÆÒ©¡ª¡ªßÁÀ­Î÷̹Ƭ

ßÁÀ­Î÷̹£¨Piracetam£©£¬£¬£¬ £¬ £¬£¬£¬£¬ÊÇÒ»ÖÖÄÜ×÷ÓÃÓÚÈÏÖª¹¦Ð§¶ø²»»áÒýÆðÕò¾²»ò´Ì¼¤ÐÔ×÷ÓõÄÒ©Î£¬£¬ £¬ £¬£¬£¬£¬²¢ÆÕ±éÓ¦ÓÃÓÚÖÐÊàÉñ¾­ÏµÍ³¼²²¡ÖÎÁÆÖС£¡£¡£ ¡£¡£¡£¡£

»îÐԳɷݣºßÁÀ­Î÷̹

»¯Ñ§Ãû³Æ£º2-Ñõ´ú-1-ßÁ¿©Íé»ùÒÒõ£°·

·Ö×Óʽ£ºC6H10N2O2     

·Ö×ÓÁ¿£º142.16

ßÁÀ­Î÷̹µÄ

Éú³¤Åä¾°

   20ÊÀ¼Í60ÄêÔ£¬£¬£¬ £¬ £¬£¬£¬£¬GABA±»Ö¤ÊµÊÇÒ»ÖÖÖ÷ÒªµÄÄÔÉñ¾­µÝÖÊÒÖÖƼÁ£¬£¬£¬ £¬ £¬£¬£¬£¬ÊÇÒ»ÖÖÓë˯ÃßÓйصÄÖ÷ÒªµÄÒÖÖÆÐÔÉñ¾­µÝÖÊ£¬£¬£¬ £¬ £¬£¬£¬£¬ÕâÒýÆðÁËÈËÃǵĸ߶ÈÖØÊÓ£¬£¬£¬ £¬ £¬£¬£¬£¬ÓëGABAÏà¹ØµÄÒ©Àíѧ±»ÒýÈëҩѧ¹¤Òµ¡£¡£¡£ ¡£¡£¡£¡£

 

1964Ä꣬£¬£¬ £¬ £¬£¬£¬£¬±ÈÀûʱÓÅʱ±È(UCB)ÖÆÒ©¹«Ë¾ºÏ³ÉÁ˦Ã-°±»ù¶¡Ëá(GABA)µÄ»·×´ÑÜÉúÎïßÁÀ­Î÷̹(1,Piracetam)£¬£¬£¬ £¬ £¬£¬£¬£¬Ä⿪·¢Æä³ÉΪÕò¾²Ò©£¬£¬£¬ £¬ £¬£¬£¬£¬È»¶ø¸ÃÒ©ËäÈ»ÓëGABAÏà¹Ø£¬£¬£¬ £¬ £¬£¬£¬£¬µ«ËüÈ´²»Ö±½ÓÓ°ÏìGABAÊÜÌ壬£¬£¬ £¬ £¬£¬£¬£¬Ò²Ã»ÓÐÓÕµ¼Ë¯ÃßµÄ×÷Ó㬣¬£¬ £¬ £¬£¬£¬£¬Ïà·´£¬£¬£¬ £¬ £¬£¬£¬£¬Giurgea²©Ê¿È´·¢Ã÷¸ÃÒ©Äܹ»Ìá¸ßÈËÃǵÄÈÏÖªÄÜÁ¦¡£¡£¡£ ¡£¡£¡£¡£

1971Ä꣬£¬£¬ £¬ £¬£¬£¬£¬¾­ÓÉÉñ¾­Ò©Àíѧ¼Ò¡¢»¯Ñ§¼ÒGiurgea²©Ê¿¼áÈͲ»°ÎµÄÑо¿£¬£¬£¬ £¬ £¬£¬£¬£¬µÚ1¸ö¾ßÓдÙÖÇ»îÐÔµÄÎ÷̹ÀàÒ©Î¡ªßÁÀ­Î÷̹ÕýʽÉÏÊС£¡£¡£ ¡£¡£¡£¡£

 

1972Ä꣬£¬£¬ £¬ £¬£¬£¬£¬Giurgea²©Ê¿Ò²Æ¾Ö¤ßÁÀ­Î÷̹Ìá³öÁË¡°´ÙÖÇÒ©£¨nootrope£©¡±µÄ¿´·¨¡£¡£¡£ ¡£¡£¡£¡£¡°nootrope¡±Ò»´Ê£¬£¬£¬ £¬ £¬£¬£¬£¬Ô´×ÔÏ£À°Ó¡ª noos´ú±íÖǻ۵ģ¬£¬£¬ £¬ £¬£¬£¬£¬tropein´ú±íÓÐÀûµÄ[1]¡£¡£¡£ ¡£¡£¡£¡£

 

ÏÖÔÚ£¬£¬£¬ £¬ £¬£¬£¬£¬ßÁÀ­Î÷̹±»ÆÕ±éÒÔΪÊÇÒ»ÖÖÄÔ´úл¸ÄÉÆÒ©£¬£¬£¬ £¬ £¬£¬£¬£¬Ö÷ÒªÓÃÓÚÖÎÁƼ±¡¢ÂýÐÔÄÔѪ¹Ü²¡¡¢ÄÔÍâÉË¡¢ÖÖÖÖÖж¾ÐÔÄÔ²¡µÈ¶àÖÖÔµ¹ÊÔ­ÓÉËùÖµÄÓ°Ïó¼õÍ˼°Çá¡¢ÖжÈÄÔ¹¦Ð§ÕÏ°­¡£¡£¡£ ¡£¡£¡£¡£Ò²¿ÉÓÃÓÚ¶ùͯÖÇÄÜ·¢Óý»ºÂý¡£¡£¡£ ¡£¡£¡£¡£

 

 

¶à°Ðµã

¸ÄÉÆÄÔ´úл

ÔÚÉñ¾­ÔªË®Æ½ÉÏ£¬£¬£¬ £¬ £¬£¬£¬£¬ßÁÀ­Î÷̹µ÷ÀíһϵÁеÝÖÊϵͳ£¨°üÀ¨µ¨¼îÄܺ͹Ȱ±ËáÄÜ£©µÄÉñ¾­×ª´ï£¬£¬£¬ £¬ £¬£¬£¬£¬¾ßÓÐÉñ¾­±£»£»£»£»£»£»£»¤ÐÔ£¬£¬£¬ £¬ £¬£¬£¬£¬²¢¸ÄÉÆÉñ¾­¿ÉËÜÐÔ£»£»£»£»£»£»£»ÔÚѪ¹ÜˮƽÉÏ£¬£¬£¬ £¬ £¬£¬£¬£¬ßÁÀ­Î÷̹¿ÉÒÔïÔÌ­ºìϸ°ûÓëѪ¹ÜÄÚƤµÄÕ³¸½£¬£¬£¬ £¬ £¬£¬£¬£¬±ÜÃâѪ¹Ü¾·ÂΣ¬£¬£¬ £¬ £¬£¬£¬£¬Ôö½ø΢ѭ»·[2]¡£¡£¡£ ¡£¡£¡£¡£

 

ßÁÀ­Î÷̹µÄ

ÁÙ´²Ó¦ÓÃ

ÈÏÖª¹¦Ð§ÕÏ°­

±ÈÀûʱµÄÑо¿Ö°Ô±¶Ô19Ïî˫䡢ο½å¼Á±ÈÕÕµÄÑо¿¾ÙÐÐÁËÆÊÎö£¬£¬£¬ £¬ £¬£¬£¬£¬Ñо¿¹¤¾ßÊÇ»¼ÓгմôÖ¢»òÈÏÖªÕÏ°­µÄ»¼Õß¡£¡£¡£ ¡£¡£¡£¡£ÕâÏîÜöÝÍÆÊÎöµÄЧ¹û֤ʵÎúʹÓÃßÁÀ­Î÷̹ºÍʹÓÃο½å¼ÁµÄÈËÖ®¼ä±£´æ²î±ð£¬£¬£¬ £¬ £¬£¬£¬£¬Áè¼Ý60%µÄ½ÓÊÜßÁÀ­Î÷̹ÖÎÁƵĻ¼ÕßÔÚCGICÆÀ·ÖÖÐÓиÄÉÆ£¬£¬£¬ £¬ £¬£¬£¬£¬Ò²¾ÍÊÇ˵Ч¹ûÊÇÕýÏòµÄ£¬£¬£¬ £¬ £¬£¬£¬£¬Åú×¢ßÁÀ­Î÷̹ÔÚ¸ÄÉÆÈÏÖªÕÏ°­·½ÃæµÄÒæ´¦£¬£¬£¬ £¬ £¬£¬£¬£¬ÎªÖ¤ÊµßÁÀ­Î÷̹ÓÃÓÚ²î±ðÈÏÖªÕÏ°­ÈËȺµÄÓÐÓÃÐÔÌṩÁËÖ¤¾Ý[3]¡£¡£¡£ ¡£¡£¡£¡£

Á­µ¶ÐÍϸ°ûѪÐ鲡

Á­µ¶ÐÍϸ°ûѪÐ鲡ÊÇÒ»ÖÖÓÉÒì³£»£»£»£»£»£»£»òÁ­×´ÑªºìÂÑ°×ÒýÆðµÄÒÅ´«ÐÔ¼²²¡£¡£¡£ ¡£¡£¡£¡£¬£¬£¬ £¬ £¬£¬£¬£¬ÕâЩ»¼Õߵĺìϸ°û¸üÈÝÒ×Õ³¸½ÔÚÄÚƤ±ÚÉÏ¡£¡£¡£ ¡£¡£¡£¡£ÕâÖÖºìϸ°ûÕ³¸½ÇãÏòÓÚÛÕ±ÕëϸѪ¹ÜѪÁ÷£¬£¬£¬ £¬ £¬£¬£¬£¬µ¼Ö¾ֲ¿×éÖ¯ËðÉ˺ÍÌÛÍ´£¬£¬£¬ £¬ £¬£¬£¬£¬³ÆΪÁ­×´Ï¸°ûΣÏ󡣡£¡£ ¡£¡£¡£¡£ßÁÀ­Î÷̹¶Ôºìϸ°û±¬·¢Á˶àÖÖÓ°Ï죬£¬£¬ £¬ £¬£¬£¬£¬Ê¹Æä³ÉΪÖÎÁÆÕâÖÖ¼²²¡µÄDZÔÚºòÑ¡Ò©Îï¡£¡£¡£ ¡£¡£¡£¡£Ò»·Ý½ÒÏþÔÚ¡¶ÁøÒ¶µ¶¡·ÉϵÄÑо¿ÏÔʾ£¬£¬£¬ £¬ £¬£¬£¬£¬ßÁÀ­Î÷̹ÖÎÁÆÁ­µ¶ÐÍϸ°ûѪÐ鲡ÓÐÓ㬣¬£¬ £¬ £¬£¬£¬£¬ÇÒÎÞ¸±×÷ÓÃ[4]¡£¡£¡£ ¡£¡£¡£¡£

³ý´ËÖ®Í⣬£¬£¬ £¬ £¬£¬£¬£¬ßÁÀ­Î÷̹ÔÚÖÎÁÆÍíÄê³Õ´ô¡¢Ñ£ÔΡ¢Öз硢¶ùͯÔĶÁÕÏ°­µÈ¶¼ÏÔʾ³öÓÐÓÃÐÔ¡£¡£¡£ ¡£¡£¡£¡£

 

×ܽá

ßÁÀ­Î÷̹ÊÇÒ»ÖÖ¸ÄÉÆÄÔ´úлÀàÒ©Î£¬£¬ £¬ £¬£¬£¬£¬ÆäÒ©Àí»úÖÆÈÔÔÚһֱ̽Ë÷ÖУ¬£¬£¬ £¬ £¬£¬£¬£¬ÏÖÔÚµÄѭ֤ҽѧ֤¾ÝÒѾ­Åú×¢Æä¾ßÓиÄÉÆÉñ¾­Ôª¹¦Ð§¡¢¸ÄÉÆ΢ѭ»·µÄ×÷Ó㬣¬£¬ £¬ £¬£¬£¬£¬ßÁÀ­Î÷̹ÉÏÊÐÖÁ½ñÒÑ50ÓàÄ꣬£¬£¬ £¬ £¬£¬£¬£¬ÒÑÆÕ±éÓ¦ÓÃÓÚÈÏÖª¹¦Ð§ÕÏ°­ºÍÄÔѪ¹Ü¼²²¡µÈµÄÁÙ´²ÖÎÁÆ£¬£¬£¬ £¬ £¬£¬£¬£¬ÇÒ¾ßÓнϺÃÖÎÁÆЧ¹û¡£¡£¡£ ¡£¡£¡£¡£

 

²Î¿¼ÎÄÏ×

[1] ËÎÑÞÁá,Ëﻶ,Àî°ØÄÈ.Î÷̹ÀàÒ©ÎïÑо¿Ï£Íû[J].ÖйúÒ©Òµ,2015,24(01):4-7.

[2] Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev. 2005 Summer;11(2):169-82.

[3] Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B. Clinical efficacy of piracetam in cognitive impairment: A meta-analysis. Dement Geriatr Cogn Disord 2002;13:217¨C224.

[4] de Araujo JT, Nero GS. Piracetam and acetamide in sickle-cell disease. Lancet. 1977 Aug 20;2(8034):411. PMID: 70630.

 

 

ÌØÊâ˵Ã÷£º±¾ÎÄÄÚÈݲ¿·ÖȪԴÒÔÉϲο¼ÎÄÏ×£¬£¬£¬ £¬ £¬£¬£¬£¬½ö×öÐÅÏ¢ÕûºÏ·ÖÏí£¬£¬£¬ £¬ £¬£¬£¬£¬²»´ú±íÈκÎÓÃÒ©½¨Ò飬£¬£¬ £¬ £¬£¬£¬£¬ÈôÓÐÇÖȨ¡¢ÐÅÏ¢ÓÐÎó»òÆäËûÒìÒ飬£¬£¬ £¬ £¬£¬£¬£¬ÇëÁªÏµÒøºÓ¼¯ÍŹÙÍø¾ÙÐÐɾ³ý£¡

 

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿